172 related articles for article (PubMed ID: 24295603)
1. Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective study.
Guo YJ; Chang MH; Chen PL; Lee YS; Chang YC; Liao YC
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e249-54. PubMed ID: 24295603
[TBL] [Abstract][Full Text] [Related]
2. D-dimer and Body CT to Identify Occult Malignancy in Acute Ischemic Stroke.
Rosenberg J; Do D; Cucchiara B; Messé SR
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105366. PubMed ID: 33039769
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis.
Schutgens RE; Beckers MM; Haas FJ; Biesma DH
Haematologica; 2005 Feb; 90(2):214-9. PubMed ID: 15710574
[TBL] [Abstract][Full Text] [Related]
4. Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke.
Gon Y; Sakaguchi M; Takasugi J; Kawano T; Kanki H; Watanabe A; Oyama N; Terasaki Y; Sasaki T; Mochizuki H
Eur J Neurol; 2017 Mar; 24(3):503-508. PubMed ID: 28026909
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer.
Kono T; Ohtsuki T; Hosomi N; Takeda I; Aoki S; Sueda Y; Ishihara K; Nakamura T; Yamawaki T; Matsumoto M
Geriatr Gerontol Int; 2012 Jul; 12(3):468-74. PubMed ID: 22233138
[TBL] [Abstract][Full Text] [Related]
6. Frequency and mechanism of ischemic stroke associated with malignancy: a retrospective series.
Álvarez-Pérez FJ; Verde I; Usón-Martín M; Figuerola-Roig A; Ballabriga-Planas J; Espino-Ibañez A
Eur Neurol; 2012; 68(4):209-13. PubMed ID: 23018798
[TBL] [Abstract][Full Text] [Related]
7. D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients.
Wang JY; Zhang GJ; Zhuo SX; Wang K; Hu XP; Zhang H; Qu LD
Neurol Res; 2018 Nov; 40(11):948-954. PubMed ID: 30317943
[TBL] [Abstract][Full Text] [Related]
8. High plasma D-dimer is a marker of deep vein thrombosis in acute stroke.
Kuwashiro T; Toyoda K; Oyama N; Kawase K; Okazaki S; Nagano K; Koga M; Matsuo H; Naritomi H; Minematsu K
J Stroke Cerebrovasc Dis; 2012 Apr; 21(3):205-9. PubMed ID: 20813546
[TBL] [Abstract][Full Text] [Related]
9. D-dimers predict stroke subtype when assessed early.
Isenegger J; Meier N; Lämmle B; Alberio L; Fischer U; Nedeltchev K; Gralla J; Kohler HP; Mattle HP; Arnold M
Cerebrovasc Dis; 2010; 29(1):82-6. PubMed ID: 19907168
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of D-dimer ELISA test in elderly patients with suspected pulmonary embolism.
Tardy B; Tardy-Poncet B; Viallon A; Lafond P; Page Y; Venet C; Bertrand JC
Thromb Haemost; 1998 Jan; 79(1):38-41. PubMed ID: 9459319
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte sedimentation rate as a marker of inflammation and ongoing coagulation in stroke and transient ischaemic attack.
Swartz JE; Jacobson BF; Connor MD; Bernstein PL; Fritz VU
S Afr Med J; 2005 Aug; 95(8):607-12. PubMed ID: 16201006
[TBL] [Abstract][Full Text] [Related]
12. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
Nozawa T; Inoue H; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2006 Apr; 109(1):59-65. PubMed ID: 15992948
[TBL] [Abstract][Full Text] [Related]
13. D-dimer, magnetic resonance imaging diffusion-weighted imaging, and ABCD2 score for transient ischemic attack risk stratification.
Cucchiara BL; Messe SR; Sansing L; MacKenzie L; Taylor RA; Pacelli J; Shah Q; Pollak ES; Kasner SE
J Stroke Cerebrovasc Dis; 2009; 18(5):367-73. PubMed ID: 19717021
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients.
Rallidis LS; Vikelis M; Panagiotakos DB; Liakos GK; Krania E; Kremastinos DT
Acta Neurol Scand; 2008 Jun; 117(6):415-20. PubMed ID: 18093263
[TBL] [Abstract][Full Text] [Related]
15. Ability of the number of territories involved on DWI-MRI to predict occult systemic malignancy in cryptogenic stroke patients.
Guo L; Wang L; Liu W
J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104823. PubMed ID: 32362555
[TBL] [Abstract][Full Text] [Related]
16. D-dimer levels and cerebral infarction in critically ill cancer patients.
Ryu JA; Bang OY; Lee GH
BMC Cancer; 2017 Aug; 17(1):591. PubMed ID: 28854911
[TBL] [Abstract][Full Text] [Related]
17. D-dimer is not a long-term prognostic marker following acute cerebral ischemia.
Squizzato A; Ageno W; Finazzi S; Mera V; Romualdi E; Bossi A; Venco A
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):303-6. PubMed ID: 16651873
[TBL] [Abstract][Full Text] [Related]
18. Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke.
Nam KW; Kim CK; Kim TJ; An SJ; Oh K; Mo H; Kang MK; Han MK; Demchuk AM; Ko SB; Yoon BW
PLoS One; 2017; 12(3):e0172793. PubMed ID: 28282388
[TBL] [Abstract][Full Text] [Related]
19. High D-dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes.
Paneesha S; Cheyne E; French K; Bacchu S; Borg A; Rose P
Br J Haematol; 2006 Oct; 135(1):85-90. PubMed ID: 16925794
[TBL] [Abstract][Full Text] [Related]
20. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
